An injectable hydrogel made from the self-assembling peptide FFFGHK — incorporating the naturally occurring bioactive peptide GHK — eliminated damaging free radicals, reduced inflammation, and significantly improved motor recovery in rats with spinal cord injuries.
Motor Recovery + Neuronal RegenerationA single six-amino-acid self-assembling peptide hydrogel significantly improved both motor function and nerve cell regrowth at the site of spinal cord injury in rats
What the researchers found
The FFFGHK peptide self-assembled into an injectable, biodegradable, anti-swelling supramolecular hydrogel that demonstrated multiple therapeutic effects:
In vitro: eliminated reactive oxygen species (ROS), inhibited inflammatory responses, rescued cell apoptosis, accelerated neuron adhesion and proliferation, and promoted differentiation of neural stem cells into neurons.
In vivo (rats with SCI): significantly enhanced recovery of autonomous motor functions and signal transduction, and promoted neuronal regeneration at the injury site. The single-component design — combining the self-assembling phenylalanine (FFF) motif with the bioactive GHK tripeptide — created a material that serves simultaneously as a structural scaffold and a therapeutic agent.
Why it matters
Spinal cord injury affects hundreds of thousands of people annually worldwide, and there are currently no effective treatments that restore function. This peptide hydrogel addresses multiple barriers to recovery simultaneously: it fights the toxic environment (ROS, inflammation) that prevents healing while providing a physical scaffold and biological signals that promote nerve regeneration. The simplicity of the design — a single six-amino-acid peptide — makes it potentially scalable and translatable.
How the study worked
The FFFGHK peptide was synthesized and characterized for self-assembly into a supramolecular hydrogel. In vitro experiments in cell culture assessed ROS elimination, anti-inflammatory effects, anti-apoptotic activity, neuron adhesion/proliferation, and neural stem cell differentiation. In vivo efficacy was tested in a rat spinal cord injury model, evaluating motor function recovery, electrophysiological signal transduction, and neuronal regeneration at the injury site.
What this study cannot tell us
The in vivo study was conducted in a rat SCI model, which has significant anatomical and physiological differences from human spinal cord injuries. Specific quantitative data on motor recovery scores and sample sizes were not provided in the abstract. Long-term outcomes beyond the study period were not assessed. The translation from rat to human SCI recovery faces major challenges given the differences in spinal cord anatomy and regenerative capacity. The anti-swelling mechanism was not fully characterized.
How to read the evidence
This is a preclinical study with both in vitro and in vivo (rat) experiments demonstrating therapeutic efficacy. While the rat SCI model is a standard preclinical platform, results require validation in larger animals and ultimately human clinical trials. Published in Acta Biomaterialia, a leading biomaterials journal.
When this study was published
Published in 2025, this is very recent work at the forefront of peptide-based biomaterials for neural repair, reflecting the latest advances in self-assembling peptide hydrogel technology.
The bigger picture
GHK (glycyl-histidyl-lysine) is a naturally occurring copper-binding peptide with well-documented wound healing, anti-inflammatory, and antioxidant properties — already used in cosmeceuticals. This study demonstrates that embedding GHK into a self-assembling peptide framework creates a multifunctional biomaterial for one of medicine's most challenging problems. It represents the convergence of peptide self-assembly science, bioactive peptide therapeutics, and regenerative neuroscience.
Questions still open
- How long does the FFFGHK hydrogel persist at the injury site before biodegrading, and is this timing optimal for nerve regeneration?
- Could combining the FFFGHK hydrogel with growth factors or stem cell therapies further enhance spinal cord repair?
- Does the copper-binding capacity of the GHK component contribute to the therapeutic effect through trace metal regulation at the injury site?
Common questions
What is GHK and why is it used in this spinal cord injury treatment?
Could this gel help paralyzed people walk again?
Read the original research
Biodegradable and anti-swelling peptide-based supermolecule hydrogel for eliminating ROS and inhibiting inflammation in acute spinal cord injury repair.
Acta biomaterialia, 205, 193-204
Citation
Zhou, Xiaolin; Guo, Yanqiu; Gao, Zhan; Lv, Gan; Wang, Xiangyang; Zhang, Mengpei; Zhou, Yunlong. (2025). Biodegradable and anti-swelling peptide-based supermolecule hydrogel for eliminating ROS and inhibiting inflammation in acute spinal cord injury repair.. Acta biomaterialia, 205, 193-204. https://doi.org/10.1016/j.actbio.2025.08.043